1) Vindesine
长春地辛
1.
The combination effectiveness of thrombin,lyophized nocardiarubra-cell wall skeleton,vindesine and cisplatine on patients with bloody malignant pleural effusion;
凝血酶联合胞必佳、长春地辛与顺铂治疗血性恶性胸腔积液疗效分析
2.
Objective To evaluate the clinical efficacy and toxicity of the two chemotherapeutic regimens GP (gemcitabine and cisplatin ) and IVP (isofosfamide, vindesine and cisplatin ) in advanced non-small cell lung cancer (NSCLC).
目的 比较化疗方案GP(吉西他滨和顺铂)和IVP(异环磷酰胺、长春地辛和顺铂)治疗晚期非小细胞肺癌(NSCLC)的疗效和毒性。
3.
OBJECTIVE To observe the efficacy and toxicity of vindesine(VDS),pirarubicin(THP),cyclophosphamide(CTX) and dexamethasone(DXM) combination therapy for non-Hodgkin s lymphoma.
目的观察应用长春地辛(VDS)、吡柔比星(THP)、环磷酰胺(CTX)、地塞米松(DXM)联合治疗非霍奇金淋巴瘤的疗效及不良反应。
2) VDS
长春地辛
1.
A Combined Therapy of Small-cell Lung Cancer Mainly with IFO DDP and VDS;
以异环磷酰胺、顺铂、长春地辛联合化疗为主综合治疗小细胞肺癌的疗效观察
2.
Clinical Comparison the Expressions of NVB and VDS Combined Regimens in the Treatment of 72 Cases of Advanced NSCLC;
异长春花碱,长春地辛联合方案治疗72例晚期非小细胞肺癌的临床对比研究
3) vindesine sulfate
硫酸长春地辛
1.
A new method for the analysis of related substances in vindesine sulfate and its injection to improve the ability of separation by RP HPLC was established.
以反相高效液相色谱法检测硫酸长春地辛及其注射剂中的有关杂质。
4) vinleurosine
长春罗辛
5) vindesine/therapeutic use
长春地辛/治疗应用
6) Vindesine sulfate for Injection
注射用硫酸长春地辛
补充资料：长春地辛
分子式：C43H55N5O7
分子量：暂无
CAS号：53643-48-4
性质：暂无
制备方法：暂无
用途：抗癌药。
分子量：暂无
CAS号：53643-48-4
性质：暂无
制备方法：暂无
用途：抗癌药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条